JPRN-UMIN000018098招募中未知
The efficacy of DAAs against the patients with chronic hepatitis and cirrhosis due to HCV - The efficacy of DAAs
Shinanomachi Liver Conference0 个研究点目标入组 300 人开始时间: 2015年6月26日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •inadequate patients
研究者
相似试验
招募中
不适用
The effect of DAAs therapy for patients with HCV infection on prognosis and incidence of HCCJPRN-UMIN000031091Graduate School of Medicine, Hokkaido University400
招募中
1 期
Efficacy of D-alanine intake in patients with chronic kidney disease; a randomized controlled pilot trialChronic kidney diseaseJPRN-jRCTs041230148Oshima Megumi24
已完成
不适用
The effect of alpha-defensin on patients with chronic pancreatitisChronic pancreatitisJPRN-UMIN000030207Hokkaido University Hospital100
招募中
不适用
Efficacy and safety of CH-001 in patients with chronic hepatitis C or NAFLD/NASH (placebo comparative study)JPRN-UMIN000006928Kyoundo Hospital40
尚未招募
2 期
Efficacy of Unani Formulation in White PatchesCTRI/2022/04/041571Rajiv Gandhi University Of Health Sciences